🔗 Share this article

Given that America continues making historic adjustments to its immunization guidelines, one figure appears unexpectedly: Høeg, an American of Danish descent sports physician and public health researcher who rose to prominence by questioning coronavirus vaccinations throughout the global health crisis and has zeroed in on alleged fatalities following Covid vaccination in her brief tenure at the Food and Drug Administration.

Scheduled Changes to Pediatric Vaccine Schedule

Health officials planned to announce sweeping revisions to the pediatric vaccine schedule recently, aligning the US with the Danish vaccine program, sources say – a significant shift that would place the US at odds with much of the international standard with little proof for public health gain. The planned update has been delayed until the coming year.

Rather than Vinay Prasad, Høeg is set to address the audience at the gathering. She was newly appointed temporary leader of the FDA’s CDER, the fifth appointee to run the division this calendar year.

A New Direction at the FDA

The acting appointment may indicate a closer partnership between the pharmaceutical and vaccine centers as Dr. Høeg and Dr. Prasad solidify control at the agency – and it signals a increased emphasis upon dismantling previously authorized vaccines at the FDA.

Dr. Høeg has frequently advocated for halting specific childhood immunization guidelines in the US to become more like Denmark, a society with comprehensive healthcare and a number of inhabitants approximately the size of Wisconsin’s.

In her initial public appearances, she has kept her attention on immunizations – usually the purview of Dr. Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than drug regulation.

Concerns Over Expertise

The appointee has no obvious experience in pharmaceutical research, regulation or leadership, which has been typical for former heads of the CBER. She has been employed at the FDA as a top consultant to the FDA chief and the vaccine center since earlier this year.

“She appears not to have the necessary background” for overseeing the pharmaceutical oversight division, stated a neurologist and psychiatrist. “She’s never run a scientific study. She lacks experience in managing a sizeable institution. She lacks background in industry regulation.”

Previous commissioners of CBER would “grasp legal statutes and the science of pharmaceutical innovation”, said Janet Woodcock. “Clearly, she has not acquired the kind of background that prior appointees who ran CBER have had.”

The drug center has an enormous portfolio at the FDA, the former commissioner pointed out.

“The public just focuses on the novel medication approvals, but the generic drug division approves a multitude of generic medications. There is also a biosimilars division, OTC medication office and other areas, and all of those must be supervised,” Dr. Woodcock explained. “The area you overlook, that is the part that I always told people is going to cause problems.”

There is also, a significant management component to the role, which supervises more than 5,000 personnel. “It is a enormous management job, if you perform it correctly,” Woodcock added.

Agency Reaction and Disputed Policies

When asked about inquiries about Høeg’s fitness for the role and whether this appointment indicates more teamwork among FDA leaders on vaccines, a press secretary said that the “questions stem from flawed presumptions”.

“This background is consistent with the functions of her job,” the spokesperson stated, pointing to the months Dr. Høeg spent counseling the agency head on “drug safety and oversight research, including computational safety modeling and vaccine surveillance”.

As the temporary head, Dr. Høeg inherits the agency head's controversial fast-track approval initiative, a controversial rapid medication authorization process that apparently concerned her predecessors. “By what process are these therapies being selected for this fast-track system? Who takes the calls?” Dr. Howard questioned. “There is a lot of lack of transparency going on at the regulatory body right now.”

In general, he remarked, “the agency looks to be trending towards more relaxed rules of most medications, aside from vaccines.”

Established Past Work on Immunizations

Regarding vaccines, Dr. Høeg has a more documented, if problematic, track record, critics observe. She published a research paper using non-validated crowd-sourced reports to assess the frequency of myocarditis after Covid immunization. She consulted for the Florida top health official Joseph Ladapo, who allegedly have modified findings to imply COVID-19 vaccinations are pose a greater threat than they are.

Part of her “policy goals” for the incoming government featured changing rules for new vaccines and ending “optional” immunizations, she stated following the vote on a audio program. At the agency, Høeg has allegedly proposed excluding teenage boys from obtaining COVID-19 vaccines.

“She’s an all-around dogmatist who commences with her preconceived notions and tailors the evidence to fit the evidence in a highly deceptive, fraudulent fashion,” Dr. Howard said.

Consolidating Power and a “Campaign of Retribution”

Høeg aligned with other dissenters, {like|